Alcohol Use Disorder (AUD) Clinical Trial
— MI-SPARCOfficial title:
The Michigan Sustained Patient-centered Alcohol-Related Care (MI-SPARC) Trial
NCT number | NCT04861792 |
Other study ID # | R18HS027076 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2021 |
Est. completion date | March 13, 2023 |
Verified date | March 2023 |
Source | Kaiser Permanente |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Unhealthy alcohol use is a major contributor to morbidity and mortality in the US. Although effective prevention for unhealthy alcohol use and medication treatment for alcohol use disorders (AUDs) can be provided in primary care (PC), they have historically not been included in routine services. As a result, most patients do not receive evidence-based prevention or treatment for unhealthy alcohol use. Several efforts have successfully implemented alcohol-related preventive care-referred to as screening and brief intervention (SBI), but efforts to increase treatment of AUDs with medications have been less successful. Moreover, implementation efforts have usually neglected smaller PC practices, in which most PC is provided. The Michigan SPARC trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, bringing extensive expertise implementing evidence-based alcohol-related care, and Altarum Institute in Ann Arbor, Michigan, bringing demonstrated success engaging over 500 small to medium Michigan-based PC practices in effective quality improvement (QI) efforts. The project builds on Altarum's innovative approach to implementing new or improved clinical care using practice facilitators to provide continuing medical education and maintenance of certification (CME/MOC) programs to PC providers, along with ongoing support for QI using evidence-based implementation strategies. The KPWHRI team recently finished the highly successful AHRQ-funded Sustained Patient-centered Alcohol-Related Care (SPARC) trial using similar implementation strategies in KP Washington, including use of electronic health records and performance monitoring and feedback, and also developed a patient decision aid to support shared decision-making between patients with high-risk drinking and/or AUDs and their PC providers. The Michigan SPARC trial combines Altarum's expertise in QI in small-medium PC practices in Michigan with KPWHRI's expertise implementing evidence-based prevention and treatment of unhealthy alcohol use-specifically alcohol SBI and medication treatment for AUDs. Specific Aims of the Michigan SPARC trial had to be markedly modified due to the trial beginning in March 2020 at the same time as the COVID pandemic. A trial was not possible. The revised aims were to describe alcohol screening, brief intervention, AUD diagnosis and initiation of medication treatment for AUD, before and after the Michigan SPARC model was implemented, in small to medium PC practices in Michigan.
Status | Completed |
Enrollment | 9590 |
Est. completion date | March 13, 2023 |
Est. primary completion date | March 13, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults age 18 years and older - Seen in primary care at a study practice during the practice's study period Exclusion Criteria: • None |
Country | Name | City | State |
---|---|---|---|
United States | Altarum Institute | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
Kaiser Permanente | Agency for Healthcare Research and Quality (AHRQ) - Funder, Altarum Institute, NORC at the University of Chicago |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevention - Screening and brief intervention | The proportion of PC patients who screen positive for unhealthy alcohol use and have BI documented in their EHR. | For Aim 1 the period up to 6 months before the launch date will be compared to the 6 month period after the launch date. | |
Primary | Treatment - Prescription of AUD medications | The proportion of PC patients who are diagnosed with AUD at a visit who also receive a prescription for medications to treat AUD and are seen for follow-up within 14 days. | For Aim 1 the period up to 6 months before the launch date will be compared to the 6 month period after the launch date. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04927364 -
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
|
N/A | |
Active, not recruiting |
NCT04618653 -
Comprehensive Process Model of AA-related Behavior Change
|
||
Recruiting |
NCT05471154 -
Non-invasive Brain Stimulation of the Prefrontal Cortex in Substance Use Disorders
|
N/A | |
Completed |
NCT05021640 -
Study of DCR-AUD in Healthy Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05064228 -
Mobile Rewarding Activity Centered Treatment
|
N/A | |
Completed |
NCT04958655 -
Mental Imagery Intervention for Alcohol Craving
|
N/A | |
Completed |
NCT05252221 -
Alcohol Telemedicine Consultation in Primary Care (ATC)
|
N/A | |
Completed |
NCT06108115 -
Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder
|
N/A | |
Not yet recruiting |
NCT06303778 -
Combining a Smartphone App With Medications to Manage Heavy Drinking
|
N/A | |
Completed |
NCT04639895 -
Cognitive Rehabilitation Through Personalized Virtual Reality and Paper-and-pencil Interventions in the Alcohol Use Disorder Treatment.
|
N/A | |
Completed |
NCT02911285 -
NAC for Treating Comorbid PTSD and SUD
|
Phase 2 | |
Recruiting |
NCT04598399 -
Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
|
N/A | |
Completed |
NCT04827056 -
Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
|
Phase 1 | |
Completed |
NCT04974645 -
Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use
|
N/A | |
Recruiting |
NCT05992272 -
Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
|
||
Completed |
NCT04229095 -
Medication Development in Alcoholism: Suvorexant Versus Placebo
|
Phase 2 | |
Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
Completed |
NCT04925570 -
The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use
|
Phase 2 | |
Active, not recruiting |
NCT05492942 -
Records for Alcohol Care Enhancement
|
N/A | |
Recruiting |
NCT05015881 -
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
|
Phase 2/Phase 3 |